fbpx

UK: CLL paid research opportunity

February 2, 2022
 Adrian Warnock

Evolve Fieldwork have a research project running on Chronic Lymphocytic Leukaemia (CLL). They are specifically looking for patients that are on or have previously undergone one of the following treatments: ibrutinib or acalabrutinib or venetoclax + rituximab or venetoclax +Obinutuzumab (not as part of a clinical trial)

The topic of the research will be to gather thoughts and perspectives about your CLL treatment experiences and what it is really like to live with CLL.

The research will involve a 45-minute pre-task followed by a 60-minute web-assisted telephone interview. The remuneration for participation will be 165 GBP.

If you are interested and would like to see if you are eligible to participate in the research, please can you complete for us the few screening questions at the following link:https://forms.office.com/r/S6zTUm9WXU

Alternatively, you can also reach out directly to Nadine atnadine.koekemoer@evolve-fieldwork.com

Connect with us

We will keep you updated with more articles like this one

Adrian Warnock
  • Adrian Warnock

  • Dr. Adrian Warnock is a medical doctor and clinical research expert who was himself diagnosed with blood cancer in May 2017. Adrian worked in the pharmaceutical industry for fifteen years helping to run the clinical trials that bring us new medicines and communicate the results. Before this he practised in the UK’s National Health Service (NHS), as a psychiatrist, for eight years.

    Adrian is a published author, the founder of Blood Cancer Uncensored, and has written a Christian blog since 2003 at Patheos. He is passionate about learning how to approach suffering with hope and compassion. Adrian's articles are not medical advice and he is not a haematologist or blood cancer doctor. Always seek individualised advice from your health care professionals. You can e-mail Adrian here.

    Medical Research and Surveys